Fierce BioTech

SEPTEMBER 30, 2024

Fierce Biotech Week Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.

Pharma Companies 52

Pharma Companies Drug Development Marketing Drugs 52

Reprocell

NOVEMBER 1, 2022

Pharma companies are legally required to test novel drugs in animal models before beginning human trials. And while animal testing has progressed thousands of therapeutics that we use today, it is not without its experimental and ethical downfalls.

Animal Testing 52

Animal Testing Pharma Companies Laboratories Drug Development 52

DrugBaron

JANUARY 31, 2024

Billions of dollars have been invested in companies promising to “revolutionise pharma R&D” through the application of artificial intelligence – but it is now clear that global pharma companies, and not just tech bro’s, are buying into the claims. And there is no doubt that there is plenty of room for improvement.

Pharma R&D 165

Pharma R&D Science Small Molecule Drugs 165

biobide

FEBRUARY 2, 2024

This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes. This treatment was developed by performing a chemical screening on zebrafish.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

DrugBank

JUNE 27, 2024

Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 72

Drugs Pharma Companies Clinical Trials Computational Chemistry 72

The Connected Lab

APRIL 8, 2020

How is AI being applied in Drug Discovery efforts? It is reported that every one of the major pharmaceutical companies has announced a partnership with at least one AI-based drug development company, but how is AI being used to facilitate drug development? Nature , vol. RARE Facts.” Smith, Simon. “36

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52

PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

H1 Blog

JULY 30, 2024

We’re curious to see what will happen over the next 12 months and how pharma companies will respond.” The Impact of Draft Guidance on Drug Development As it stands, drug development is an expensive endeavor, costing approximately $2.3 billion and taking upwards of 15 years.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

Metabolite Tales Blog

DECEMBER 19, 2023

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group A Metabolite Bioanalysis Working Group comprised of experts from 14 different pharma companies have proposed recommendations around best practice in metabolite bioanalysis during drug development.

Pharma Companies 52

Pharma Companies Drug Development Compliance Trials 52

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development 52

Drug Development Pharma Companies Marketing Drugs 52

Drug Target Review

MARCH 15, 2024

Cultural differences between the UK and mainland Europe were still quite different then but we settled in Southampton and I later went to University in Brighton, studied for a D.Phil, and found a job at a Pharma company. She has held leadership positions in Project Management, Technical Operations, and Business Development.

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

Drug Target Review

MAY 23, 2023

9 Academic scientists researching natural products often struggle with the pitfalls of drug development. Exploring this unexploited resource through revived natural product research represents a new avenue for pharma companies to take on the challenges of IBD and other diseases.

Drugs 75

Drugs Small Molecule Production Disease 75

Dark Matter Blog

JUNE 21, 2023

As a small biotech company with new technology at the frontier of the known drug discovery universe, it may feel like you’re charting a course alone in a dark, cold, and empty void with hailing frequencies open, but with no incoming transmissions. But you would be wrong.

Small Molecule 52

Small Molecule RNA Pharma Companies Science 52

The Pharma Data

OCTOBER 30, 2020

With an average of only 5 – 10 projects awarded to EU companies by the FDA each year, this development represents a landmark achievement for RCPE and reflects the potential impact of these projects within the global pharma industry.

FDA 52

FDA Engineering Pharma Companies Pharmaceuticals 52

PerkinElmer

FEBRUARY 18, 2021

Which high throughput screening (HTS) approach is the most productive in finding hits for drug development: target-based or phenotypic? By a 3:1 margin, PerkinElmer found top Pharma screens for a specific target. Pharma companies must improve productivity and efficiency amidst rising R&D costs.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

The Pharma Data

OCTOBER 20, 2020

MD Anderson has historically collaborated with biotechs and pharma companies to conduct cancer therapy research. Through investment from the Cancer Focus Fund and the support of MD Anderson, we hope to advance worthwhile new treatments past the traditional hurdles in the drug development process.” . Source link.

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

DrugBaron

JULY 19, 2022

Constructing larger and more diverse screening libraries was, for a while, the competitive advantage of the largest pharma companies. Around the turn of the century, increases in computing capabilities opened up an opportunity to expand the search space by several more orders of magnitude, with the arrival of in silico screening.

Small Molecule 100

Small Molecule Drugs DNA Pharma Companies 100

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. of total revenue).

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

The Pharma Data

NOVEMBER 10, 2020

Yohan Tessier, Vice President of Commercial Operations & Strategic Development at Mispro, explained that this is critical in expediting their clients’ time to market. We’re seeing a trend in drug development towards super complex and highly-targeted compounds, which requires researchers to conduct a number of preclinical studies.

Marketing 52

Marketing Science Pharma Companies Research 52

Predictive Oncology

FEBRUARY 7, 2023

That means a lot of wasted effort and resources for drugmakers given that even before a molecule enters Phase I trials, typically five to eight years of development have already been invested in the product. This is going to disrupt the way that drug development is done,” Bush said, by changing the way companies choose drug indications.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Elrig

APRIL 29, 2024

She is currently a Senior drug discovery scientist working across Cell Engineering, Cell Biology and Functional Genomics teams, using CRISPR/Cas9 and Next Generation Sequencing for target identification, target validation and drug development in the oncology disease area. big pharma or startups/spin off? What pro/cons?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Vial

FEBRUARY 19, 2024

Rich McCormick: Drug development can be quite challenging. Rich McCormick: How do you strike a balance between the clinical aspects and the commercial demands in your role as the CEO of a pharma company? With this construct, hopefully we’ll be seeing quite a bit of benefit for patients. Ahmed Hamby: Thank you.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

Codon

FEBRUARY 13, 2024

But thankfully there are groups — from charities and start-ups to the non-profit arms of major pharma companies — looking specifically at more public-health-focused approaches to scaling phage therapy for these parts of the world.

Therapies 118

Therapies DNA Virus Clinical Trials 118

Agency IQ

JULY 12, 2024

The examples : 1) a health care provider posting on the internet about unsubstantiated claims that a class of cholesterol drugs causes Alzheimer’s; 2) a celebrity influencer recommending off-label use (i.e., In fact, a “big pharma” company denying the accuracy of a claim may even serve to legitimize that claim in the eyes of some people.

FDA 40

FDA Regulations Production Science 40

Altus Drug Development

JUNE 28, 2022

New classes of medicines and new mechanisms of action for old drugs may be discovered via drug repositioning. As a novel drug development approach, drug repositioning has been crucial to several achievements of modern medicinal research. appeared first on Altus Drug Development.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

DECEMBER 30, 2020

One of the reasons they expect VC spending in biopharma to expand is that during 2020, particularly from March through about July, many pharma companies, if able, paused their clinical trials. BioMarin Pharmaceutical’s Roctavian for hemophilia B.

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug & Device Law

SEPTEMBER 1, 2023

We observed oral argument the other day in a case that could have a significant impact on potential liability under California tort law for pharma companies and all other innovators. In the end, counsel urged that imposing undue liability would discourage drug development. In Gilead v. Superior Court , No. A165558 (Cal.

Production 64

Production Marketing Drugs Pharma Companies 64